Record · inventcures.github.io
A biomarker-directed, multi-center phase II/III study of ctDNA molecular response adaptive immuno-chemotherapy in patients with non-small cell lung cancer (BR.36).
$whoami : echo “tp53(ashish), ml + {medicine, biology} tinkerer” - tp53(ashish)’s home on the interwebs · 30 September 2026 · 2 min read
A post on inventcures.github.io, published 30 September 2026, has not been cited by any blog yet (corpus.blog, measured 13 October 2026).
A record is what was published and who pointed at it. The text of the post is not shown here: read it at the source, or at its Wayback capture.
0blogs citing
| Period | Blogs | Links |
|---|---|---|
| All time | 0 | 0 |
| Last 90 days | 0 | 0 |
| Last 30 days | 0 | 0 |
| Last 7 days | 0 | 0 |
| Words blogs link it with | 0 |
|---|---|
| External links | 0 |
| Length | 453 |
Cited by
No blog we hold has cited this post yet.
Links from this post
This post links to no other pages.
Similar posts
Meet the 2026 STARs: Julie Deutsch, MD
cancerresearch.org
10 Sept 2026
What a Low Tumor Mutation Burden Means for Your Cancer
biologyinsights.com
3 Oct 2026
Dene’s story: helping the future of cancer treatment
guysandstthomas.nhs.uk
1 Oct 2026
How this CRI CLIP Investigator Tracks Cancer in Real Time
cancerresearch.org
29 Apr 2026
AI Is Not Enough: Rethinking the Foundations of Drug Discovery in Oncology
communities.springernature.com
2 Oct 2026
What Is the Normal Range for a Ki-67 Score?
biologyinsights.com
3 Oct 2026
Bezisterim – the Best Long COVID Drug Trial Yet? BioVie Aims for a Big, Phase III Trial
healthrising.org
27 Sept 2026
Is TTF-1 Positive Good or Bad in Tumor Diagnosis?
biologyinsights.com
4 Oct 2026
Don’t Feed the Shield: How Cancer Uses Antioxidants to Survive Treatment
thomashealthblog.com
2 Oct 2026
Something wrong here? Report a problem